Literature DB >> 27509031

Characterization of Laminin Binding Integrin Internalization in Prostate Cancer Cells.

Lipsa Das1, Todd A Anderson2, Jaime M C Gard2, Isis C Sroka3, Stephanie R Strautman4, Raymond B Nagle2,5, Colm Morrissey6, Beatrice S Knudsen7, Anne E Cress2,4,8.   

Abstract

Laminin binding integrins α6 (CD49f) and α3 (CD49c) are persistently but differentially expressed in prostate cancer (PCa). Integrin internalization is an important determinant of their cell surface expression and function. Using flow cytometry, and first order kinetic modeling, we quantitated the intrinsic internalization rates of integrin subunits in a single cycle of internalization. In PCa cell line DU145, α6 integrin internalized with a rate constant (kactual ) of 3.25 min-1 , threefold faster than α3 integrin (1.0 min-1 ), 1.5-fold faster than the vitronectin binding αv integrin (CD51) (2.2 min-1 ), and significantly slower than the unrelated transferrin receptor (CD71) (15 min-1 ). Silencing of α3 integrin protein expression in DU145, PC3, and PC3B1 cells resulted in up to a 1.71-fold increase in kactual for α6 integrin. The internalized α6 integrin was targeted to early endosomes but not to lamp1 vesicles. Depletion of α3 integrin expression resulted in redistribution of α6β4 integrin to an observed cell-cell staining pattern that is consistent with a suprabasal distribution observed in epidermis and early PIN lesions in PCa. Depletion of α3 integrin increased cell migration by 1.8-fold, which was dependent on α6β1 integrin. Silencing of α6 integrin expression however, had no significant effect on the kactual of α3 integrin or its distribution in early endosomes. These results indicate that α3 and α6 integrins have significantly different internalization kinetics and that coordination exists between them for internalization. J. Cell. Biochem. 118: 1038-1049, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  ENDOSOMES; INTEGRIN; INTERNALIZATION KINETICS; LAMININ; PROSTATE CANCER

Mesh:

Substances:

Year:  2017        PMID: 27509031      PMCID: PMC5553695          DOI: 10.1002/jcb.25673

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  49 in total

Review 1.  Role of integrins in cell invasion and migration.

Authors:  John D Hood; David A Cheresh
Journal:  Nat Rev Cancer       Date:  2002-02       Impact factor: 60.716

Review 2.  The laminin binding integrin alpha6beta1 in prostate cancer perineural invasion.

Authors:  Isis C Sroka; Todd A Anderson; Kathy M McDaniel; Raymond B Nagle; Matthew B Gretzer; Anne E Cress
Journal:  J Cell Physiol       Date:  2010-08       Impact factor: 6.384

Review 3.  Integrin Regulation of Epidermal Functions in Wounds.

Authors:  Whitney M Longmate; C Michael Dipersio
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-03-01       Impact factor: 4.730

4.  Characterization of integrin subunits, cellular adhesion and tumorgenicity of four human prostate cell lines.

Authors:  C M Witkowski; I Rabinovitz; R B Nagle; K S Affinito; A E Cress
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

5.  Lgl2 and E-cadherin act antagonistically to regulate hemidesmosome formation during epidermal development in zebrafish.

Authors:  Mahendra Sonawane; Hans Martin-Maischein; Heinz Schwarz; Christiane Nüsslein-Volhard
Journal:  Development       Date:  2009-03-04       Impact factor: 6.868

Review 6.  A central role for vesicle trafficking in epithelial neoplasia: intracellular highways to carcinogenesis.

Authors:  James R Goldenring
Journal:  Nat Rev Cancer       Date:  2013-10-10       Impact factor: 60.716

7.  alpha3beta1 Integrin is required for normal development of the epidermal basement membrane.

Authors:  C M DiPersio; K M Hodivala-Dilke; R Jaenisch; J A Kreidberg; R O Hynes
Journal:  J Cell Biol       Date:  1997-05-05       Impact factor: 10.539

8.  Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression.

Authors:  Z Werb; P M Tremble; O Behrendtsen; E Crowley; C H Damsky
Journal:  J Cell Biol       Date:  1989-08       Impact factor: 10.539

Review 9.  Laminin-binding integrins and their tetraspanin partners as potential antimetastatic targets.

Authors:  Christopher S Stipp
Journal:  Expert Rev Mol Med       Date:  2010-01-18       Impact factor: 5.600

10.  Rab-coupling protein coordinates recycling of alpha5beta1 integrin and EGFR1 to promote cell migration in 3D microenvironments.

Authors:  Patrick T Caswell; May Chan; Andrew J Lindsay; Mary W McCaffrey; David Boettiger; Jim C Norman
Journal:  J Cell Biol       Date:  2008-10-06       Impact factor: 10.539

View more
  12 in total

1.  Regulation of inside-out β1-integrin activation by CDCP1.

Authors:  Sara G Pollan; Fangjin Huang; Jamie M Sperger; Joshua M Lang; Colm Morrissey; Anne E Cress; C Y Chu; Neil A Bhowmick; Sungyong You; Michael R Freeman; Danislav S Spassov; Mark M Moasser; William G Carter; Shakti Ranjan Satapathy; Kavita Shah; Beatrice S Knudsen
Journal:  Oncogene       Date:  2018-03-07       Impact factor: 9.867

2.  Integrin α-3 ß-1's central role in breast cancer, melanoma and glioblastoma cell aggregation revealed by antibodies with blocking activity.

Authors:  Daniel F Lusche; Michael R Klemme; Benjamin A Soll; Ryan J Reis; Cristopher C Forrest; Tiffany S Nop; Deborah J Wessels; Brian Berger; Rebecca Glover; David R Soll
Journal:  MAbs       Date:  2019-04-16       Impact factor: 5.857

3.  Novel Regulation of Integrin Trafficking by Rab11-FIP5 in Aggressive Prostate Cancer.

Authors:  Lipsa Das; Jaime M C Gard; Rytis Prekeris; Raymond B Nagle; Colm Morrissey; Beatrice S Knudsen; Cindy K Miranti; Anne E Cress
Journal:  Mol Cancer Res       Date:  2018-05-14       Impact factor: 5.852

4.  Integrin α6β4E variant is associated with actin and CD9 structures and modifies the biophysical properties of cell-cell and cell-extracellular matrix interactions.

Authors:  Mengdie Wang; James P Hinton; Jaime M C Gard; Joe G N Garcia; Beatrice S Knudsen; Raymond B Nagle; Anne E Cress
Journal:  Mol Biol Cell       Date:  2019-03-13       Impact factor: 4.138

5.  Integrin α5/ITGA5 Promotes The Proliferation, Migration, Invasion And Progression Of Oral Squamous Carcinoma By Epithelial-Mesenchymal Transition.

Authors:  Yun Deng; Quan Wan; Wangxiang Yan
Journal:  Cancer Manag Res       Date:  2019-11-13       Impact factor: 3.989

Review 6.  Integrin trafficking in cells and tissues.

Authors:  Paulina Moreno-Layseca; Jaroslav Icha; Hellyeh Hamidi; Johanna Ivaska
Journal:  Nat Cell Biol       Date:  2019-01-02       Impact factor: 28.824

Review 7.  Integrin Inhibitors in Prostate Cancer.

Authors:  Maylein C Juan-Rivera; Magaly Martínez-Ferrer
Journal:  Cancers (Basel)       Date:  2018-02-06       Impact factor: 6.639

8.  HDAC Inhibition Counteracts Metastatic Re-Activation of Prostate Cancer Cells Induced by Chronic mTOR Suppression.

Authors:  Jasmina Makarević; Jochen Rutz; Eva Juengel; Sebastian Maxeiner; Jens Mani; Stefan Vallo; Igor Tsaur; Frederik Roos; Felix K-H Chun; Roman A Blaheta
Journal:  Cells       Date:  2018-09-01       Impact factor: 6.600

9.  ADAP1 promotes invasive squamous cell carcinoma progression and predicts patient survival.

Authors:  Avery Van Duzer; Sachiko Taniguchi; Ajit Elhance; Takahiro Tsujikawa; Naoki Oshimori
Journal:  Life Sci Alliance       Date:  2019-12-02

10.  Development and application of two novel monoclonal antibodies against overexpressed CD26 and integrin α3 in human pancreatic cancer.

Authors:  Gustavo A Arias-Pinilla; Angus G Dalgleish; Satvinder Mudan; Izhar Bagwan; Anthony J Walker; Helmout Modjtahedi
Journal:  Sci Rep       Date:  2020-01-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.